133 related articles for article (PubMed ID: 34628817)
1. [Correlation of conventional ultrasound features and related factors with BRAFV600E gene mutation in papillary thyroid carcinoma].
Lv Y; He X; Yang F; Guo L; Qi M; Zhang J; Wang H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 35(10):925-929. PubMed ID: 34628817
[No Abstract] [Full Text] [Related]
2. [Correlation between conventional ultrasound features and BRAFV600E gene mutation and central lymph node metastasis in thyroid papillary carcinoma].
Zhang J; Feng Y; He X; Bai Q; Lv Y; Sun K; Qi M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Mar; 36(3):184-188. PubMed ID: 35193339
[No Abstract] [Full Text] [Related]
3. Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma.
Yoon JH; Han K; Lee E; Lee J; Kim EK; Moon HJ; Park VY; Nam KH; Kwak JY
PLoS One; 2020; 15(2):e0228968. PubMed ID: 32053670
[TBL] [Abstract][Full Text] [Related]
4. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
Gao X; Luo W; He L; Cheng J; Yang L
Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas.
Li Y; Wang Y; Li L; Qiu X
Sci Rep; 2022 Jul; 12(1):12674. PubMed ID: 35879379
[TBL] [Abstract][Full Text] [Related]
6. The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology.
Moon HJ; Kwak JY; Kim EK; Choi JR; Hong SW; Kim MJ; Son EJ
Ann Surg Oncol; 2009 Nov; 16(11):3125-31. PubMed ID: 19644722
[TBL] [Abstract][Full Text] [Related]
7. Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation.
Stojanović S; Šelemetjev S; Đorić I; Rončević J; Janković Miljuš J; Živaljević V; Išić Denčić T
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1835-1842. PubMed ID: 32651027
[TBL] [Abstract][Full Text] [Related]
8. Integrating BRAF
Zhang Z; Zhang X; Yin Y; Zhao S; Wang K; Shang M; Chen B; Wu X
BMC Cancer; 2022 Apr; 22(1):461. PubMed ID: 35473554
[TBL] [Abstract][Full Text] [Related]
9. A different prognostic value of BRAFV600E mutation positivity in various age groups of patients with papillary thyroid cancer.
Takacsova E; Kralik R; Waczulikova I; Zavodna K; Kausitz J
Neoplasma; 2017; 64(1):156-164. PubMed ID: 27881018
[TBL] [Abstract][Full Text] [Related]
10. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
Pelizzo MR; Boschin IM; Barollo S; Pennelli G; Toniato A; Zambonin L; Vianello F; Piotto A; Ide EC; Pagetta C; Sorgato N; Torresan F; Girelli ME; Nacamulli D; Mantero F; Mian C
Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381
[TBL] [Abstract][Full Text] [Related]
11. High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules.
Li XJ; Mao XD; Chen GF; Wang QF; Chu XQ; Hu X; Ding WB; Zeng Z; Wang JH; Xu SH; Liu C
Medicine (Baltimore); 2019 Jul; 98(28):e16343. PubMed ID: 31305422
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A systematic review and meta-analysis.
Chen B; Shi Y; Xu Y; Zhang J
Clin Endocrinol (Oxf); 2021 May; 94(5):731-742. PubMed ID: 32816325
[TBL] [Abstract][Full Text] [Related]
13. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract][Full Text] [Related]
14. BRAFV600E Immunohistochemistry in Papillary Thyroid Carcinomas: Relationship Between Clinical and Morphological Parameters.
Kombak FE; Özkan N; Uğurlu MÜ; Kaya H
Turk Patoloji Derg; 2019; 35(2):83-91. PubMed ID: 30632125
[TBL] [Abstract][Full Text] [Related]
15. Application of Ultrasound Shear Wave Elastography Combined With BRAFV600E Mutation for the Diagnosis of Papillary Thyroid Carcinoma.
Xu L; Haitao R; Li Z
Ultrasound Q; 2023 Dec; 39(4):199-205. PubMed ID: 37543733
[TBL] [Abstract][Full Text] [Related]
16. Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer.
Yoon S; An YS; Lee SJ; So EY; Kim JH; Chung YS; Yoon JK
Medicine (Baltimore); 2015 Dec; 94(48):e2063. PubMed ID: 26632889
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the association of BRAFV600E mutation and Ki-67 overexpression with clinical and pathological characteristics in papillary thyroid cancer.
Espenbetova M; Krykpayeva A; Zamanbekova Z; Zhumanbaeva Z; Azizov B; Mukanova A; Glushkova N
Radiat Environ Biophys; 2021 May; 60(2):233-241. PubMed ID: 33774706
[TBL] [Abstract][Full Text] [Related]
18. The Clinicopathological Results of Thyroid Cancer With BRAFV600E Mutation in the Young Population of Fukushima.
Iwadate M; Mitsutake N; Matsuse M; Fukushima T; Suzuki S; Matsumoto Y; Ookouchi C; Mizunuma H; Nakamura I; Nakano K; Sakamoto A; Hirokawa M; Ito M; Naganuma H; Hashimoto Y; Shimura H; Yamashita S; Suzuki S
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32827026
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen receptor alpha in papillary thyroid carcinoma: association with clinical features and BRAFV600E mutation.
Liu S; Jiao B; Li S; Zhao L; Zheng W; Wang K; Xu J; Tian Y; Liu C; Gui Z; Zhang L
Jpn J Clin Oncol; 2021 Jul; 51(7):1051-1058. PubMed ID: 33893504
[TBL] [Abstract][Full Text] [Related]
20. Can ultrasound be as a surrogate marker for diagnosing a papillary thyroid cancer? Comparison with BRAF mutation analysis.
Seo JY; Kim EK; Baek JH; Shin JH; Han KH; Kwak JY
Yonsei Med J; 2014 Jul; 55(4):871-8. PubMed ID: 24954313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
